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M O L E C U L A R  B I O L O G Y
A molecular mechanism for the enzymatic methylation 
of nitrogen atoms within peptide bonds
Haigang Song1,2, Niels S. van der Velden3, Sally L. Shiran1, Patrick Bleiziffer4, Christina Zach3, 
Ramon Sieber3, Aman S. Imani5, Florian Krausbeck4, Markus Aebi3, Michael F. Freeman5,  
Sereina Riniker4*, Markus Künzler3*, James H. Naismith2,6,7*
The peptide bond, the defining feature of proteins, governs peptide chemistry by abolishing nucleophilicity of the 
nitrogen. This and the planarity of the peptide bond arise from the delocalization of the lone pair of electrons on the 
nitrogen atom into the adjacent carbonyl. While chemical methylation of an amide bond uses a strong base to gen-
erate the imidate, OphA, the precursor protein of the fungal peptide macrocycle omphalotin A, self-hypermethylates 
amides at pH 7 using S-adenosyl methionine (SAM) as cofactor. The structure of OphA reveals a complex catenane- 
like arrangement in which the peptide substrate is clamped with its amide nitrogen aligned for nucleophilic attack 
on the methyl group of SAM. Biochemical data and computational modeling suggest a base-catalyzed reaction 
with the protein stabilizing the reaction intermediate. Backbone N-methylation of peptides enhances their protease 
resistance and membrane permeability, a property that holds promise for applications to medicinal chemistry.
INTRODUCTION
The defining feature of the peptide bond is the delocalization of the 
lone pair of electrons on the nitrogen atom. As a consequence, the N–C 
bond has partial double bond character, making it shorter, stronger, and 
rotationally locked—factors that shape protein structure—when com-
pared to a normal single bond. While the lone pair in sp3- hybridized 
nitrogen is highly nucleophilic, the delocalized lone pair of the sp2- 
hybridized amide nitrogen has no nucleophilic character. Breaking 
conjugation to make the nitrogen nucleophilic requires overcoming the 
barrier to rotation around the C–N bond estimated at 77 kJ mol−1 (1), 
and that, alongside the pKa (where Ka is the acid dissociation con-
stant) [estimated in dimethyl sulfoxide (DMSO) > 20 (2)], presents a 
formidable barrier to reaction. Consequently, the chemical methyl-
ation of an amide bond typically deprotonates the nitrogen using 
strong bases, but this can epimerize amino acids, remove protecting 
groups, or lead to other unwanted side reactions (1). Many natural 
products, including those from nonribosomal peptide synthetase 
(NRPS) pathways and ribosomally synthesized and posttranslationally 
modified peptide (RiPP) pathways, contain N-methylated amides. 
However, it is the free amino terminus of peptides or amino acid 
building blocks that is methylated before peptide bond formation 
(3–6). Synthetic approaches commonly use methylated building blocks 
mirroring biology’s strategy seen in NRPSs; however, in solid-phase 
peptide synthesis, methylated amino acids pose significant technical 
challenges (7). The drive for methylated peptides comes from the ob-
servation that amide methylation results in a pharmaceutically useful 
increase in cell membrane permeability and oral availability (8, 9), 
illustrated by cyclosporine A. The ability to easily methylate complex 
peptides could transform the field of peptide therapeutics by allowing 
access to beyond the “rule of five” compounds (10) that are capable of 
disrupting protein-protein interactions.
Omphalotin A is a fungal peptide macrocycle comprising of 12 
residues of which 9 are methylated at the backbone amide (Fig. 1A) (11), 
and it is toxic to the plant parasitic nematode Meloidogyne incognita. 
Amide methylation was assumed to arise from an NRPS pathway (12). 
The discovery that omphalotins are ribosomally synthesized (12) means 
that nature has evolved a catalytic strategy for amide methylation of 
already formed peptide bonds. Omphalotin A derives from the 
C terminus of the OphA protein, and it is the OphA protein that 
methylates its own C terminus using S-adenosyl methionine (SAM) 
(12). The C terminus is subsequently cleaved off and macrocyclized 
to give the final product; 1 mol of enzyme gives 1 mol of product 
(12, 13). The biological chemistry of amides is limited, and the most 
well-known example is the N-glycosylation of proteins in which 
an oligosaccharide is transferred to the side-chain amide nitrogen 
of the Asn in the Asn-X-Ser/Thr consensus sequence by the enzyme 
oligosaccharyltransferase (14). The current model for the reaction 
mechanism, based on structural and biochemical data of the bacte-
rial oligosaccharyltransferase PglB (15, 16), proposes that two metal- 
 bridged aspartic acids form strong hydrogen bonds to the primary 
amide protons, resulting in the nitrogen twisting out of conjugation 
and thus reverting to sp3 hybridization and regaining its nucleo-
philicity. Direct methylation of an amide occurs in the ansamitocin 
pathway (non-RiPPs) by an unknown mechanism (17).
Here, we report the structure of the peptide amide methyl-
transferase OphA including complexes with cofactor [SAM and 
S-adenosyl homocysteine (SAH)], cofactor analog, substrate, and 
product. Site- directed mutagenesis and structural biology have 
identified residues essential in anchoring the substrate amide adja-
cent to SAM. Biochemical analysis supports a base-catalyzed mecha-
nism. With these data and guided by quantum mechanical (QM) 
calculations, we propose that OphA uses a mechanism in which the 
enzyme facilitates the removal of the amide proton and stabilizes 
the resulting negative charge, thereby activating the amide bonds 
for methylation.
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Structure of OphA
Automethylation of OphA (Fig. 2A) occurs during heterologous over-
expression in Escherichia coli, and the extent of methylation correlates 
with the time and temperature of induction but is a slow reaction 
(12, 13). The originating fungus is long-lived (11), permitting the 
possibility of a slow native catalysis. The analysis of partially methyl-
ated OphA protein–established methylation is directional (N to C) 
(12). The full-length native protein was refractory to crystallization, 
but an 18-residue C-terminally truncated variant (OphAC18), which 
lacks the sequence that is methylated, was first purified, crystallized, 
and phased using a selenomethionine variant (Fig. 1B and table S1). 
Structures with SAM and SAH bound were determined by preincu-
bating the protein with the cofactor prior to crystallization; high- 
performance liquid chromatography (HPLC) was used to confirm 
bound cofactor identity. Apart from the addition of the methyl group, 
the structures of the two complexes are identical [root mean square 
deviation (rmsd) of 0.6 Å over 684 C atoms]. The monomer has a 
compact N-terminal domain (Thr7 to Lys251), which binds SAM/
SAH and is most closely related in structure to the uroporphyrinogen- 
III C-methyltransferase (UIIIMT) (rmsd of 2.4 Å over 197 C atoms; 
fig. S1A) (18), which has a similar back-to-back dimer arrangement 
(fig. S1B). OphA has an insertion of 14 residues (Cys175 to Asn189), 
which forms a loop that, along with another loop (Asp67 to Ser71), 
folds over the SAM-binding site and creates an extended enclosed 
cavity (Fig. 1B and fig. S1A). These loops partly occupy the pocket 
used to bind uroporphyrinogen-III in UIIIMT (19). SAM is bound to 
the protein by an extensive network of interactions (fig. S1C). Even 
with prolonged dialysis at 25°C in the presence of 2 M urea, we were 
unable to remove SAM from OphAC18 to generate an apoprotein 
(4 M urea unfolded the protein that we were unable to refold). 
Compared to the Pro242-adenosine (of SAM) interaction in UIIIMT 
(which binds SAM very tightly) (19), OphAC18 makes more exten-
sive van der Waal interactions between Val243 and adenosine. UIIIMT 
operates by deprotonating the porphyrin ring with a pair of arginine 
residues to make a potent carbon nucleophile reaction (19).
The C-terminal region (Ala252 to Met378) of OphAC18, referred 
to as clasp domain hereafter, is not found in other methyltrans-
ferases and comprises extended strands and a helical bundle (Lys322 
to Met378; Fig. 1B). The monomer has the appearance of a ring, with 
the C-terminal domain forming a thin band (Fig. 1B), which is 
closed by interactions between Leu333 and Pro335 from the clasp do-
main with Leu27 and Ser31 from the N terminus. OphA is a dimer in 
which the N-terminal (SAM-binding) domains are arranged facing 
away from the dimer interface (Fig. 1C and fig. S1B). The clasp do-
main of one OphAC18 monomer wraps around the N-terminal 
domain of the other monomer, giving the dimer the appearance of 
two interlocked rings (catenane), a structure that is rare among pro-
teins [reviewed in (20)].
Fig. 1. Omphalotin A and OphA. (A) The primary structure of OphA protein consists of a methyltransferase domain (orange), the clasp domain (green), and the C-terminal 
substrate peptide (blue). The dashed red line indicates the C termini of the OphAC18 and C6 constructs. Omphalotin A derives from N to C self-methylation of the 9 of 12 
possible amides within this sequence. (B) OphAC18 monomer shown as a cartoon with SAM cofactor shown as space fill (oxygen, red; nitrogen, blue; carbon, yellow; 
and sulfur, green). The N-terminal methyltransferase (orange) is connected to a C-terminal domain (green) forming a ring. An extended loop (in cyan and denoted by an 
asterisk) sits above the active site. (C) The dimer has a pseudo interlocking ring (catenane) arrangement, the other monomer is colored pink (N-terminal methyltransferase 
domain) and gray (C-terminal clasp domain). The clasp terminal domain wraps around the loops that cover the active site of the other monomer.
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A second variant of OphA, truncated at Gly411 (OphAC6; Fig. 1A), 
containing the core peptide, is catalytically active with methylation of 
up to seven residues (Fig. 3A) (12). Complete methylation of OphAC6 
occurs over a similar time frame as native OphA (12), suggesting that 
this truncated version is a valid model for the full-length enzyme. 
Isolation and purification of OphAC6 after a short (2 hours) induc-
tion in E. coli yielded a less extensively methylated form (predomi-
nantly triply methylated; Fig. 2A). Upon further in vitro incubation 
with SAM, the (fully) seven-times methylated form is obtained in a 
time-dependent manner (Fig. 2A and fig. S2A) with an estimated 
kcat,App of 0.12 hour−1 in bis-tris (pH 7.6) (comparable to an estimated 
rate in E. coli kcat,App of 0.32 hour−1; fig. S2B). This similarity led us to 
exclude any catalytic requirement for an E. coli protein or metab-
olite. The enzyme is faster at higher pH [kcat,App of 0.19 hour−1 in N- 
cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer, pH 10.0]. The 
1.7 Å OphAC6 structure determined after incubation with SAM 
(Fig. 2B) revealed additional density for eight residues of the core 
peptide (compared to OphAC18) bound in the active site of the other 
monomer (fig. S3). Electron density shows four N-methylated am-
ides (Fig. 2C and fig. S3A). The structure is otherwise essentially iden-
tical to OphAC18 (rmsd of 0.6 Å over 688 C atoms) with no notable 
conformational changes of the residues that comprise the binding 
site. For ease of discussion, we split the protein into three sections: 
the N-terminal (methyltransferase) domain, the clasp domain, and 
the C-terminal substrate peptide (Fig. 1A). Inspection of the exper-
imental maps reveals that while the positions of substrate backbone 
atoms are unambiguous, density for the side chains is suggestive of 
some heterogeneity in the register of the bound substrate peptide. 
The electron density indicates that a mixture of SAM (0.3) and SAH 
(0.7) is present in the crystal (fig. S3A); thus, we denote this com-
plex OphAC6-SAH/M. HPLC analysis shows that the protein as 
isolated from E. coli contains almost exclusively SAH (fig. S3B) with 
only a small amount of SAM exchange in solution, suggesting that dis-
placing SAH with SAM is very unfavorable when the substrate pep-
tide is present, in line with the observed slow catalytic turnover rate 
in vitro. Cocrystallization with SAH does not result in any structural 
change, and the map now shows no density for the SAM methyl group 
(fig. S3A); this complex is denoted OphAC6-SAH. The location of the 
Fig. 2. Co-complexes of OphAC6. (A) Mass spectrometry (MS) analysis of typically digested peptides shows that OphAC6 can be isolated in a partially methylated 
form (after a 2-hour induction in E. coli), which, upon incubation with SAM in vitro [overnight (o/n) and after 3 days], becomes increasingly methylated. (B) The C-terminal 
substrate peptide (colored dark blue) in monomer A inserts into the active-site monomer B (and vice versa; the substrate peptide of monomer B is cyan). The dimer structure 
is otherwise colored as in Fig.  1C. The substrate peptide binding site forms a tunnel. The orientation is rotated 180° from Fig.  1C. (C) A zoomed-in view (i−3 to i+1 range) 
of simulated-annealing Fo-Fc omit electron density contoured at 2 for the OphAC6-SAH/M structure. The electron density shows methylated amides. Full electron 
density for all structures is shown in fig. S3. Carbons are shown in cyan, oxygen in red, nitrogen in blue, and methylation sites in orange. (D) The OphAC6-SAH/M complex 
shows Ile410, which is not methylated, opposite SAH/M (denoted position i) and so represents a product complex. Residues that have already been methylated are N-terminal 
to position i and shown with an orange ball and stick. The substrate peptide (shown as sticks) makes a number of hydrogen bonds with conserved residues.
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cofactor relative to the protein is identical in both the OphAC18 
and OphAC6 complexes. The sub strate peptide sits in the extended 
active-site tunnel with the amide nitrogen of Ile410 (we define the 
amide in this location as “i” hereafter) pointing toward the methyl 
group of SAM; the N(amide)-C(SAM)-S angle is 171°, close to the 
180° required for an SN2 attack (Fig. 2D). The carbonyl of the residue 
at position i is hydrogen-bonded to the backbone amide of Asn106. 
The  angle between residues i and i+1 is 0°. Consequently, the amide 
nitrogen atoms are arranged cis to each other, and the main chain 
twists 90° (Fig. 2D). The peptide carbonyl at i−3 hydrogen-bonds to 
the side chain of Tyr63, at i−2 to the side chain of Tyr98, and at i−1 
to both Tyr66 and Tyr76. Arg72 hydrogen- bonds to Tyr76 and makes 
a polar contact with the carbonyl at residue i+1 (the C-terminal res-
idue, Gly411). The side chain at the i−2 position sits in a well-defined 
pocket formed with Ile44, Tyr63, and Tyr98. The methyl on the amide at 
position i−2 makes van der Waals contacts with Val243, while a meth-
yl group on the i−1 amide would contact Tyr66 (Fig. 2D). The side 
chains at i−1 and i−3 both sit in large hydrophobic pockets, while 
the side chains at i−4, i−5, and i−6 are exposed to solvent. In both 
solution and crystal, neither Ile410 nor Gly411 of OphAC6 is methyl-
ated. The substrate side chains do not make any specific contacts 
with OphA, consistent with the protein’s ability to methylate differ-
ent residues (Gly, Val, Ile, Met, Thr, and Ala) (12, 13).
Identification of key residues
Sequence analysis shows that residues that bind to the substrate pep-
tide are conserved in proteins from closely related fungi (fig. S5). 
Mutants Y63F, Y66F, Y76F, R72A, R72K, Y98A, Y98F, Q172A, and 
Fig. 3. Key residues for methylation. (A) MS analysis of typically digested peptides of OphAC6 mutants after purification. Y63F, Y66F, Q172A, and W400A variants show 
reduced methylation, while R72A, R72K, Y76F, Y98F, and Y98A mutants show no detectable methylations at all. The W400A mutation alters the mass of the tryptic peptide and 
is shown with a different mass scale. (B) MS analysis of typically digested peptides of in vitro assay of mutants with SAM. After 12 days of incubation, Y98A shows obvious 
single methylation, and R72A shows methylation at the detection limit, while Y76F shows no methylation. An increase in single methylation was observed for R72A in the pres-
ence of 200 mM guanidine. (C) The inactive mutant R72A has the substrate peptide (i−3 to i+3 range) bound at the active site with Trp400 opposite SAM at position i. This 
substrate peptide conformation cannot undergo methylation as the amide nitrogen points away from SAM and is denoted flipped or inactive. The carbon atoms of the sub-
strate peptide are colored gray, other atoms are colored as above. (D) Inactive R72A (cyan) and Y76F (green) complexes with SAH have structures in which the substrate 
peptide reverts to the “active” conformation. The R72A-SAM structure with the flipped/inactive conformation is shown for comparison with the same color scheme as in Fig.  3C.
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W400A of OphAC6 were expressed in E. coli. Y76F and Y98A led 
to highly aggregated protein, and only a small amount could be pu-
rified for analysis; very little folded material was obtained for Y98F, 
but no methylation was detected. Y63F, Y66F, Q172A, and W400A 
showed methylation either upon purification or after a short incu-
bation with SAM (Fig. 3A and fig. S6) but have reduced activity. 
Y76F, R72A, R72K, and Y98A were unmethylated even after 3 days 
of overexpression in E. coli (Fig. 3A). During prolonged (12 days) in-
cubation, there was some evidence for a very small amount of methyl-
ation in the Y98A mutant (>100-fold reduced in vitro activity), but 
not in the Y76F mutant (Fig. 3B). Careful examination of R72A sup-
plemented with guanidine after a 12-day incubation of SAM repro-
ducibly showed a methylated species (Fig. 3B and fig. S6). We were, 
however, unable to unambiguously confirm methylation of R72K at 
12 days. Y63F, Y66F, Y76F, R72A, Y98A, and W400A were incubated 
with SAM and analyzed. HPLC analysis showed displacement of SAH 
by SAM in Y76F, R72A, and Y98A upon incubation (fig. S3B), whereas 
the other three mutants showed very little displacement by SAM. 
Electron density of the cofactor in the Y76F, R72A, and Y98A com-
plexes was consistent with the HPLC analysis (fig. S3, A and B, and 
table S1), showing that SAM bound. In the R72A-SAM complex (rmsd 
of 0.7 Å over 720 C atoms with OphAC6-SAH), peptide bonds of 
the substrate residues i−1 and i are flipped 180° relative to the con-
formation observed in OphAC6 and Y63F-SAH. Although the side 
chain of residue i+1 sits in the same pocket as seen in the OphAC6 
protein, its backbone has a different hydrogen bond arrangement 
(Fig. 3C). Consequently, the amide nitrogen at position i (Trp400) 
points away from SAM (Fig. 3C) and is no longer aligned for methyl-
ation. The same “flipped” arrangement of the substrate peptide is 
observed for SAM complexes of Y98A (Trp400 at position i) and Y76F 
(Ile402 at position i) (figs. S3A and S7). The flipped peptide results in 
Arg72 adopting an alternative conformation. A different conformation 
of Tyr98 is seen in inactive mutant complexes (Y76F-SAM, Y76F-SAH, 
and R72A-SAH). Despite the large conformational change in sub-
strate peptide, conformations of other OphAC6 residues are essen-
tially unaltered, pointing to rigidity at the active site. The electron 
density in the Y66F active mutant suggests that both the active and 
flipped substrate conformers as well as two Arg72 conformers are 
present (fig. S3A), but disorder prevented firmer interpretation. In 
addition, complexes R72A-SAH and Y76F-SAH show similar active 
conformation of the substrate peptide (Fig. 3D).
Discounting mechanisms
Since no plausible amino acid is positioned to directly remove the 
proton from the amide, we considered disruption of conjugation akin 
to N-linked glycosyl transferase (15), in which two strong hydrogen 
bonds (thus requiring a primary amide) are made to Asn, but the 
OphA structure does not support this mechanism. We next consid-
ered nucleophilic addition to the carbonyl at i−1 to form a tetrahedral 
carbon (cf. serine protease). Among the protein side chains, TYR66, TYR76, 
Fig. 4. Substrate peptide and sinefungin coordination in the active site. (A) The simulated annealing Fo-Fc omit electron density (3) for sinefungin in OphAC6 Y63F 
and W400A complex. The HPLC analysis in fig. S3B shows some residual SAH remains. Carbon atoms are shown in yellow, sulfur in dark yellow, oxygen in red, and nitrogen 
in blue. (B) The OphAC6 W400A sinefungin structure represents a substrate complex and shows an active arrangement of the substrate peptide. The same color scheme 
and perspective as in Fig.  2D are used. (C) In both OphAC6 W400A (and Y63F) sinefungin complex structures, there is 3.1 to 3.3 Å hydrogen bond between the nitrogen 
atoms of sinefungin and the substrate amide. The arrangement of atoms is consistent with the SN2 attack by the amide on the cofactor. The same color scheme and 
perspective as in Fig.  4B are used. (D) Replacing SAH with SAM (in silico) shows that SAM would create van der Waal clashes with the amide; this extremely close contact 
is predicted to stabilize the SN2 transition state. (E) The inactive mutant R72A-SAM complex, where the anchoring interactions between substrate and enzyme are disrupted, 
avoids this steric clash. The enzyme does not significantly rearrange to tolerate this change in substrate conformation.
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or TYR98 could plausibly act as the nucleophile, (21). Y66F re-
tains activity, and Tyr76, although within 4 Å of the carbonyl, 
has a Bürgi-Dunitz (44°) angle incompatible with attack, so both pos-
sibilities were discarded. Both Tyr66 and Tyr76 are, however, well po-
sitioned to stabilize the resulting tetrahedral carbon by hydrogen 
bonding. Tyr98 has plausible (but not ideal) Flippin-Lodge (−19°) and 
Bürgi-Dunitz (149°) angles. However, it is 5.5 Å from the carbonyl, 
its tetrahedral intermediate would create multiple clashes (with SAM, 
the side chain at position i and the main chain at position i−1), and 
no base is positioned to deprotonate it, leading us to exclude this 
mechanism. We also considered whether a water molecule could per-
form this attack and form a geminal diol intermediate. The reaction 
in the presence of H218O shows no 18O incorporation in the peptide, 
and the structure shows no water or base appropriately positioned 
for this reaction, arguing against such a mechanism. Further, a 
geminal diol intermediate would be predicted to give rise to peptide 
bond cleavage at the very least as an otherwise unwanted side reac-
tion, which was not observed. Finally, formation of a tetrahedral 
intermediate would seem inconsistent with the observed decreased 
methylation rate (kinetic isotope effect of 3) in vitro in D2O (fig. S9).
Active-site geometry
Since it was not possible to obtain a fully occupied SAM complex 
with any active protein, we used sinefungin (fig. S4A), an inactive 
SAM analog, to obtain two OphAC6 complexes (active mutants 
Y63F and W400A). HPLC analysis shows that the sinefungin/SAH 
ratio is 0.7:0.3 in Y63F and W400A (fig. S3B), consistent with the 
electron density (Fig. 4A and fig. S3A) of the cofactors, and thus, 
these structures are substrate complex mimics. Superposition of the 
Y63F sinefungin complex with OphAC6-SAH shows that the pro-
tein (rmsd of 0.6 Å over 363 C atoms), the common cofactor atoms 
(rmsd of 0.2 Å over 25 common atoms), and the common substrate 
backbone atoms (positions i−3 to i+1; rmsd of 0.7 Å over 20 com-
mon backbone atoms) are positioned near identically (fig. S4B). 
Superposition of both sinefungin complexes with the OphAC6 
Y63F-SAH, OphAC18-SAM, and OphAC18-SAH complexes shows 
similar consistency in the protein structure, cofactor, and where pres-
ent substrate positions. We conclude that the extensive hydrogen- 
bonding network at the active site and the catenane-like arrangement 
lead to a highly rigid active site. In both sinefungin complexes, the 
two nitrogen atoms (sinefungin and amide) approach close enough to 
form a hydrogen bond (distance varies between 3.1 and 3.3 Å; Fig. 4C). 
Using structural superposition, we noted that placing (in silico) the 
larger SAM molecule into the SAH complex places the methyl group 
approximately 2.5 Å from substrate amide nitrogen (Fig. 4D). This 
clash is likely the reason why we have been unable to obtain fully 
occupied SAM complexes with active proteins. Although close con-
tacts have been observed between SAM and its substrate in a number 
of structures (22–25), OphA appears to have the shortest distance.
Mutations that delete hydrogen bonds between the substrate pep-
tide and protein and inactivate the enzyme (R72A, Y76F, Y98F, and 
Y98A) have the same “inactive” or flipped conformation of the sub-
strate peptide (fig. S7). We therefore hypothesize that, by disrupting 
anchoring interactions, the flipped conformation can be adopted to 
relieve the steric clashes between SAM and the amide that would 
otherwise occur (Fig. 4E). We predict that removal of the methyl 
group of SAM by changing to SAH would remove the “driving force” 
for the flipped conformation. The structures of R72A and Y76F with 
SAH do show the active conformation (Fig. 3D).
Mechanism for methylation
QM calculations show that deprotonation of the amide must occur 
prior to SN2 attack (fig. S8); notably, the educt is higher in energy 
than the intermediate due to the steric clash between SAM and the 
substrate. In all crystal structures, a water molecule, hydrogen- bonded 
to the amine of cofactor, is conserved 5.9 Å from the amide (Fig. 2D). 
Molecular dynamics (MD) and QM calculations show that this and 
other water molecules are mobile (Fig. 5A). Calculations show that 
water can function as the base (Figs. 5B and 6A) to remove the amide 
proton to generate the imidate. This process is similar to the base- 
catalyzed proton exchange of amides occurring in proteins at moder-
ate pH (26). The hydrogen-bonding network of the water may enhance 
its basicity (Figs. 2D and 4B). The resulting negatively charged oxygen 
of the imidate would be stabilized by hydrogen bonds to Tyr66 and Tyr76. 
A barrier of 5.3 kcal/mol was calculated for formation of imidate. The 
observed kinetic isotope effect of around 3 and the reactions’ pH pro-
file are consistent with such a base-catalyzed mechanism (fig. S9).
Fig. 5. Mechanistic calculations and the role of water. (A) Structure of the sim-
plified model used in the QM calculations, optimized with the B3LYP functional 
(59, 60). Water molecules observed in the MD simulation were considered. SAM is 
shown in yellow, the substrate in cyan, and key residues in the binding pocket in 
pink. Apolar hydrogens are omitted for clarity. (B) Energy profile of the proposed 
two-step reaction obtained from the QM calculations. Results using the B3LYP func-
tional (59, 60) are shown in black, and results using the TPSSH functional are shown in 
orange. QM calculations require a defined location of the proton in the intermediate 
state for convergence. The deprotonated carboxyl group of SAM was used as the 
ultimate destination; however, other routes are plausible. Perfect SN2 alignment of the 
methyl group of SAM was not observed in the model system and level of theory used.
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The pKa of imidate is not known, but the pKa of trichloro imidate has 
been reported as 11.2 (27), higher than the pKa of 10 commonly esti-
mated for Tyr. The Tyr76-Arg72 couple is reminiscent of the Lys-Tyr couple 
found in short-chain dehydrogenases/reductases (SDR) enzymes (28), 
where the positive charge stabilizes the tyrosinate anion. Proton transfer 
from Tyr76 to the oxyanion would yield the imidic acid tautomer. The imidic 
acid tautomer of an amide has recently been observed by neutron 
diffraction in an unrelated enzyme where it plays a role in catalysis (29).
The sp2 electron lone pair on the deprotonated nitrogen atom is ide-
ally positioned for SN2 attack of the methyl group of SAM (Fig. 6A). 
Our calculations estimate a barrier of 19.1 kcal/mol for the SN2 at-
tack (Fig. 5B). The heights of the barriers in the proposed mecha-
nism are within the range typically found in enzymatic reactions (30). 
We propose that the close arrangement of reactants in OphA stabi-
lizes the SN2 transition state (TS-2; Fig. 5B) (electrostatic preorgani-
zational model) (31). After methylation, to reset the machinery for 
the next step, SAM displaces SAH. However, for SAM to fully bind, 
the methylated amide at position i will have to translocate to posi-
tion i−1 to avoid clashing (Fig. 6B). There is an approximately 180° 
dihedral angle between the substrate amide nitrogen atoms at i+1 
Fig. 6. Proposed mechanism of methylation. (A) The conserved water molecule acts as base to remove the proton from the substrate to generate the imidate. The 
imidate is stabilized by hydrogen bonds to Tyr66 and Tyr76. Arg72 could stabilize tyrosinate and thus proton-transfer from Tyr76 to yield imidic acid (shown bracketed), 
which is essentially the formation of the imidic acid tautomer. SAM is shown in simplified form; the chemical structure is given in fig. S4A. (B) The displacement of SAH 
with SAM would create an impossible steric clash with the newly methylated amide; we propose that these clashes drive the required movement of the substrate (a 180° 
rotation and one residue translation). We suggest that the flipped conformation seen in Fig.  3C resembles an intermediate in the translocation process.
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and i−1; thus, as the substrate peptide translocates through the active 
site, its peptide bond must also “flip.” We speculate that the flipped 
conformation of the substrate (seen in R72A, Y98A, and Y76F SAM 
complex structures) resembles an intermediate arrangement that oc-
curs during translocation (Fig. 6B).
The amide bond is taught as the example of how resonance domi-
nates chemical properties; the lone pair on the nitrogen atom, once 
conjugated, does not act as a nucleophile. It is because of this formi-
dable kinetic barrier that the biological methylation of amide bonds, 
as opposed to amino acids, was discounted. We propose a mecha-
nism in which nature has evolved an elegant solution to this fasci-
nating chemical puzzle. Harnessing the ability to methylate amide 
bonds of synthetic peptides at neutral pH in water to enhance their 
protease resistance and cell membrane permeability has significant 
applications in medicinal chemistry.
METHODS
Protein expression and purification
Insertion of Tobacco etch virus protease (TEV) cleavage sites after 
N-terminal his-tag and site- directed mutagenesis of OphA was carried 
out using a published protocol (32) with KOD Hot Start DNA Poly-
merase. All the proteins were overexpressed in E. coli BL21 (DE3) 
cells. All mutants were introduced into the OphAC6 construct. For 
protein expression, cells were grown at 37°C in Terrific Broth medium 
to OD600 (optical density at 600 nm) of around 1.0 and then cooled 
down to 16°C in ice-cold water bath (cold shock) before induction 
with 0.2 mM isopropyl- -D-thiogalactopyranoside (IPTG) for 20 hours. 
For the expression of Y76F, cells were harvested after induction for 
4 hours using 0.2 mM IPTG at 16°C due to cell death after overnight 
induction. For purification, cells were resuspended in lysis buffer 
[25 mM tris-HCl (pH 8.0), 500 mM NaCl, 10% glycerol, lysozyme 
(0.2 mg/ml; Sigma), DNase I (25 g/ml; Sigma), and EDTA-free cocktail 
protease inhibitor (Roche Applied Science)] for 1 hour in a cold room. 
Cells were then lysed using a cell disrupter at 30 kpsi (Constant System 
Ltd.), and the cell lysate was cleared by centrifugation (40,000g for 
30 min) at 4°C. The supernatant was loaded on a 20-ml nickel HisTrap 
FF column (GE Healthcare), washed with lysis buffer, and eluted 
with 250 mM imidazole. To remove imidazole and his-tag, eluents 
were dialyzed against 25 mM tris-HCl (pH 8.0), 10% glycerol, and 
100 mM NaCl overnight in the presence of TEV protease at 4°C 
and loaded onto a second nickel column. The flow-through fractions 
were concentrated and subjected to size-exclusion chromatography 
(Superdex S200 or S75, GE Healthcare) preequilibrated with 20 mM 
tris-HCl (pH 8.0), 10% glycerol, and 100 mM NaCl. Fractions con-
taining pure proteins were collected and concentrated to 64 mg/ml. 
Purification of OphAC6 and mutants followed the same procedure 
except for the absence of NaCl in all the purification buffers. EDTA 
(2 mM) was added to the flow-through fractions of the second nickel 
column to avoid precipitation during concentration. Concentrated 
protein was applied onto a gel filtration column, and fractions corre-
sponding to the dimer were collected, concentrated to 30 to 60 mg/
ml, and stored in 20 mM tris-HCl (pH 8.0), 10% glycerol.
For the expression of selenomethionine-substituted OphAC18 
(Se-OphAC18), 50 ml of E. coli BL21 (DE3) cells was grown over-
night in LB medium, spun down at 2500g for 10 min at room tempera-
ture, washed twice with phosphate-buffered saline, and transferred into 
1 liter of M9 medium containing kanamycin (50 g/ml). Cells were then 
grown at 37°C to an OD600 of 0.8, before the addition of lysine, threonine, 
and phenylalanine at a final concentration of 100 mg/liter and of 
leucine, isoleucine, and valine at a final concentration of 50 mg/liter. 
Protein expression was induced with 0.2 mM IPTG and 40 mg/liter 
of selenomethionine and expressed at 18°C for 20 hours. Protein was 
purified using the same methods as previously described except for 
the presence of 5 mM -mercaptoethanol in all the purification buffers. 
After the gel filtration column, the protein was stored in 20 mM 
tris-HCl (pH 8), 10% glycerol, and 1 mM tris(2-carboxyethyl)phosphine 
(TCEP). The incorporation of selenium was confirmed by electrospray 
ionization–time-of-flight (ESI-TOF) MS.
To obtain OphAC6 with limited in vivo methylation (OphAC6-2h), 
cells were grown to an OD600 of 1.2 and then cold-shocked and in-
duced with 0.4 mM IPTG for 2 hours before harvesting. Protein was 
purified as before and concentrated to 11.6 mg/ml and stored in buf-
fer containing 25 mM tris-HCl (pH 8.0), 10% glycerol, and 2 mM TCEP.
In vitro assay of OphAC6 and its mutants
To test the in vitro activity, OphAC6-2h and its mutants R72A, 
R72K, Y76F, Y98A, and Q172A were incubated at a concentration of 
4 mg/ml with 5 mM SAM in 50 mM tris-HCl (pH 8.0). The extent of 
methylation at different time points was analyzed using trypsin diges-
tion and tandem MS (MS/MS) (Fig. 3, A and B, and fig. S2A).
In vitro guanidine rescue assay of OphAC6-R72A
To determine whether guanidine can rescue the activity of R72A, 
OphAC6-R72A was incubated with 5 mM SAM in the presence of 
200 mM guanidine in 50 mM tris (pH 8.0). Methylation was then 
determined by trypsin digestion and MS/MS (Fig. 3B and fig. S6).
pH profile assay of OphAC6-2h
To determine the pH rate profile of OphAC6, OphAC6-2h (4 mg/ml) 
was incubated with 5 mM SAM in appropriate buffers with a pH range 
from 4 to 10 (pH 4.0 to 5.0, 50 mM sodium citrate; pH 6.0 to 7.5, 50 mM 
bis-tris; pH 7.5 to 9.0, 50 mM tris; pH 9.0 to 10, 50 mM CHES). OphA 
precipitated at pH 4.0 and 5.0 sodium citrate buffer immediately, 
and reaction solution turned turbid after a 15-hour incubation at 
pH 6.0 bis-tris and pH 7.0 tris-HCl. The reactions were quenched 
after 15 hours by adding an equivalent volume of 8 M urea and fur-
ther incubated for 1 hour. To make sure 4 M urea quenches the re-
action, native OphAC6-2h was treated with 4 M urea and 5 mM 
SAM in tris-HCl for 1 hour. The samples were then diluted four 
times into ammonium bicarbonate (pH 8.5) and digested overnight 
with trypsin at 37°C (fig. S2B).
Solvent kinetic isotope effect
D2O of 99.9% isotope purity from Sigma-Aldrich was used to pre-
pare buffers and SAM stocks in D2O. To prepare OphAC6-2h in 
D2O, half of the OphAC6-2h proteins concentrated from gel fil-
tration fractions were extensively buffer-exchanged into 25 mM tris 
buffer prepared in D2O (pD 8.0, where pD = pH* + 0.4, and pH* is 
the reading number on the pH meter) containing 10% glycerol at 
room temperature. The other half of OphAC6-2h proteins were 
stored in 25 mM tris (pH 8.0) containing 10% glycerol. Both pro-
teins in H2O and D2O were aliquoted and frozen at −80°C for later 
experiments. To determine the solvent kinetic isotope effect, parallel 
reactions containing OphAC6-2h (4 mg/ml) and 5 mM SAM were 
carried out in 50 mM tris buffer (pH 8.0) or in 50 mM tris buffer in 
D2O (pD 8.0) for 7 hours before being quenched in 4 M urea. To 
determine the solvent viscosity effect on the reaction, another set of 
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parallel reactions using a different batch of protein was performed 
in 50 mM tris-HCl (pH 8.0) containing varied concentrations of 
glycerol (0 and 9%) as the viscosigen. Glycerol (9%) has the same 
solvent viscosity as D2O. Methylation of individual reactions was 
analyzed similarly.
18O incorporation experiments
OphAC6-2h was buffer-exchanged into 25 mM tris (pH 8.0) in 
H218O several times to the desired concentration (H218O content was 
estimated to be 95%). Reactions were performed with SAM (at 4 mg/ml 
and 5 mM) for 24 hours at room temperature before freezing. The 
resulting products were examined by ESI-TOF MS. The results were 
identical to those in normal H2O.
Ligand identification (SAM, SAH, and sinefungin)  
in OphA variants
OphA variants (OphAC18, OphAC6, Y63F, Y66F, R72A, Y76F, Y98A, 
and W400A) were quenched with trichloroacetic acid (TCA). Precipi-
tation was removed before the supernatant was injected into HPLC-
MS. To test whether SAH can be exchanged with SAM or sinefungin, 
OphAC6, Y63F, Y66F, R72A, Y76F, Y98A, and W400A at a concen-
tration of about 30 to 40 mg/ml were incubated with 6 mM SAM or 
10 mM sinefungin overnight before extensive dialysis or diafiltration. Y63F 
at a concentration of 30 mg/ml was also incubated with 50 mM sinefungin 
before extensive diafiltration. Around 50 crystals grown from conditions 
containing Y63F (30 mg/ml) and 50 mM sinefungin were fished, washed 
twice in its mother liquor, and then transferred into a 1.5-ml tube before 
quenched with TCA. All the quenched samples were analyzed with an 
analytical C18 reversed-phase column on HPLC-MS from Agilent.
ESI-TOF MS and intact mass measurement
The protein sample (20 l at 10 pM/l) was desalted on-line through a 
Waters MassPREP column (2.1 mm × 10 mm), eluted with a gradient 
from solvent A [2% CH3CN, 97% H2O, 1% formic acid (FA)] to sol-
vent B (97% CH3CN, 2% H2O, 1% FA), and delivered to a Waters 
LCT electrospray ionization mass spectrometer precalibrated using 
myoglobin. An envelope of multiple charged signals was obtained 
in positive ionization from 500 to 2000 mass/charge ratio (m/z) and 
deconvoluted using MaxEnt 1 software over the range of 44–48 kDa 
to 1 Da resolution to give the molecular mass of the protein.
nLC-ESI-MS/MS analysis
Method 1
Samples were diluted to 10 M (10 l) with 25 mM ammonium bicar-
bonate and were digested at 37°C overnight using sequencing- grade 
trypsin (Promega) at 1:50. One picomole of the resultant peptides 
was aliquoted for MS analysis. Nanoliquid chromatography (nLC)–
MS/MS data were recorded on a Sciex 5600+ mass spectrometer 
equipped with the Eksigent 2D Ultra NanoLC system using a Thermo 
Scientific Pepmap C18 column (75 m × 15 cm) and trap (2 cm) in 
trap-elute configuration. The sample was held on the trap and washed 
for 5 min with loading buffer A (2% CH3CN, 98% H2O, 0.05% triflu-
oroacetic acid). The trap was switched in line with the column, 
and elution was performed with a linear gradient using eluent A (2% 
CH3CN, 98% H2O, 0.1% FA) and increasing eluent B (98% CH3CN, 
2% H2O, 0.1% FA). The gradient was 95% A/5% B (at 0 min) linear to 
60% A/40% B (at 6 min), linear to 5% A/95% B (at 9 min), held at 
5% A/95% B until 12 min, linear to 95% A/5% B (at 14 min), and 
held at 95% A/5% B for 14 to 20 min. Mass spectra were acquired in 
positive-ion mode in information-dependent acquisition mode by 
performing 150 ms of MS followed by 80 ms of MS/MS analysis of 
the 10 most intense peaks seen by MS. These masses were then ex-
cluded from analysis for the next 10 s. MS spectra were acquired 
from 400 to 1350 m/z, and MS/MS spectra were acquired from 95 to 
2000 m/z. MS/MS data were extracted using the SCIEX PeakView 
software and analyzed using the Mascot 2.6 search engine (Matrix 
Science) against a sequence database containing OphA (and mutants). 
The data were searched with tolerances of 20 ppm for the precursor 
and 0.1 Da for fragment ions, trypsin as the cleavage enzyme, and 
three missed cleavages. A methyl modification (+14.01565 atomic 
mass unit monoisotopic) was added to the modification database for 
V, G, I, and A and used as a variable modification. The potential 
methylation sites were further verified by manual interpretation of 
subsequent analysis under the same conditions as above but utiliz-
ing product ion mode scanned specifically for the masses of interest of 
the C-terminal trypsin-digested peptide (and mutants) in the various 
methylated states. The MS spectra were used to create extracted ion 
chromatograms of the masses of interest ±0.05 m/z, and the peak 
areas were measured using the PeakView software.
Method 2
In vitro samples (10 l) were transferred into 1.7-ml Protein LoBind 
tubes (Eppendorf). After denaturing for 1 hour using 6 l of 8 M urea, 
a final concentration of 0.5 M ammonium bicarbonate, 2 mM TCEP 
(pH 8.0), and Trypsin Gold (Promega) in a molar ratio of 1:50 was 
added to the sample and incubated overnight at 37°C. The samples 
were then desalted and purified using C18 ZipTips (Millipore) and 
eluted with 90% acetonitrile (ACN), 0.1% FA. After drying the sam-
ples in a SpeedVac (Eppendorf), peptides were resuspended in 15 l 
of 20% ACN, 0.1% FA, and transferred to glass vials for MS analysis. 
An injection volume of 4 l was used for MS samples. HPLC-MS/MS 
data were recorded on a Thermo Scientific Fusion mass spectrometer 
equipped with a Dionex Ultimate 3000 UHPLC system using a nLC 
column (200 mm × 75 m) packed using Vydac 5-m particles with a 
300 Å pore size (Hichrom Limited). A 75-m emitter with a 10-m 
tip was used for electrospray (New Objective). Elution was performed 
with a linear gradient using water with 0.1% (v/v) FA (solvent A) and 
ACN with 0.1% (v/v) FA (solvent B) at a flow rate of 0.3 l/min. The 
column was equilibrated with 20% solvent B for 5 min, which was 
followed by a linear increase of solvent B to 85% over 32 min and a 
final elution step with 85% solvent B for 2 min. Mass spectra were ac-
quired in positive-ion mode with the following settings: spray voltage at 
2200 V and an S-lens level at 60. Full MS was done at a resolution of 
60,000 [automatic gain control (AGC) target, 4 × 105; maximum ion trap 
(IT), 50 ms; range, 300 to 1800 m/z], and data-dependent MS/MS was per-
formed at a resolution of 15,000 (AGC target, 5 × 105; maximum IT, 
500 ms; isolation window, 2.2) using higher-energy collisional dis-
sociation (HCD) with a stepped normalized collision energy of 14, 18, 
and 22. The inclusion list contained masses of the trypsinized fragments 
encoding the omphalotin peptide (or one of the variants) and its different 
methylation states. Data were processed using Thermo Fisher Xcalibur 
software and MaxQuant, as previously described (12).
Crystallization
All crystals were obtained using freshly prepared proteins from the 
dimer fractions of gel filtration chromatography. To obtain complex 
crystals of OphAC18 or OphAC6, proteins were incubated with 
3 mM SAM or SAH prior to crystallization. Hanging drop vapor 
diffusion method was used for all crystals unless otherwise specified.
 o
n
 Septem
ber 6, 2018
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Song et al., Sci. Adv. 2018; 4 : eaat2720     24 August 2018
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
10 of 12
Crystals of “apo” OphAC18 (in reality, predominantly bound 
with SAM) and OphAC18 in complex with SAM were obtained at 
16°C at a concentration of 40 to 50 mg/ml in the condition contain-
ing 0.06 M NaBr, 2.67% 1,6-hexanediol, 0.1 M MES (pH 6.0), 14% 
polyethylene glycol (PEG) 6000. Crystals appeared within 1 week, 
continued to grow within 2 weeks, and were then transferred to the 
reservoir solution supplemented with 25% glycerol and 5% PEG 
6000 before flash freezing in a nitrogen stream. The complex of OphAC18 
(50 mg/ml) with SAH was crystallized using sitting drop method in 
a condition containing 0.04 M ammonium citrate tribasic, 0.1 M 
sodium citrate (pH 5.5), and 27% PEG monomethyl ether (MME) 
5000. Crystals grew to full size within 2 weeks and were then trans-
ferred to their mother liquor supplemented with 10% PEG MME 5000 
before flash freezing. The Se-OphAC18 (30 mg/ml) SAM complex 
was crystallized in a condition containing 0.2 M NaCl, 0.1 M bis-tris 
(pH 6.0), and 20% PEG 3350. Crystals appeared within 2 days and 
matured within 2 weeks. These crystals were flash-frozen in mother 
liquor supplemented with 20% PEG 3350.
Complex crystals of OphAC6 (30 mg/ml) with SAM or SAH, or 
mutant Y65F (30 mg/ml) with SAM, were obtained in a condition 
containing 0.02% octyl -d-glucopyranoside, 0.2 M KCl, 0.1 M bis-tris 
(pH 6.5), and 20% PEG 4000. Crystals were transferred in the reservoir 
solution supplemented with 20% PEG 4000 and flash-frozen in liquid 
nitrogen.
For crystallization of OphAC6 mutants (Y63F, Y66F, Y76F, Y98A, 
R72A, and W400A in complex with SAM, and Y76F and R72A in com-
plex with SAH), 1 l of protein at a concentration of 30 to 50 mg/ml 
was mixed with 1 l of reservoir solution [0.3 to 0.4 M KSCN, 1.5 to 
1.9 M sodium malonate, and 0.1 M bicine (pH 9.0)]. Two shapes of 
crystals, brick-shaped and octahedral-shaped, appeared for Y63F, 
Y66F, R72A, and Y98A with SAM, while only brick-shaped crystals 
were observed for Y76F with SAM or SAH and for R72A with SAH. 
All crystals were flash-frozen in their mother liquor supplemented 
with 0.7 to 0.9 M sodium malonate.
For crystallization of OphAC6 mutants (W400A and Y63F) in 
complex with sinefungin, protein (20 to 30 mg/ml) was incubated with 
10 mM sinefungin overnight at 4°C before crystallization. Brick-shaped 
crystals appeared within 2 days and matured within 2 weeks in the 
condition containing 0.3 to 0.4 M KSCN, 0.1 M bicine (pH 8.0 for 
Y63F and pH 8.5 for W400A), and 1.3 to 1.5 M sodium malonate. 
Crystals were then soaked in 10 mM sinefungin for 2 days and then 
transferred to a cryoprotectant (mother liquor supplemented with 
1.4 to 1.7 M sodium malonate and 2 mM sinefungin) before flash 
freezing in liquid nitrogen. To increase the occupancy of sinefungin 
in the Y63F mutant, protein (30 mg/ml) was incubated with 50 mM 
sinefungin for 3 days before crystallization. After 1 week, crystals were 
soaked in 70 mM sinefungin overnight before flash freezing in liquid 
nitrogen.
Data collection, reduction, and refinement
X-ray diffraction data were recorded at either Diamond Light Source 
beamline I04-1 ( = 0.9281 Å), I03 ( = 0.9763 Å), or I24 or collected 
in-house, on a Rigaku 007HFM copper ( = 1.54 Å) rotating anode 
x-ray generator with a Saturn 944 charge-coupled device (CCD) detec-
tor at 100 K. Data were reduced, integrated, and scaled using a tool-
box autoPROC (33–35), xia2 (36–38), or HKL2000(39); OphAC6 
Y76F-SAM complex data were reindexed to P21212 in CCP4(40) and 
further merged with Aimless in CCP4 (40). Automated structure solu-
tion pipeline CRANK2 (41) was used for experimental phasing using 
selenium single-wavelength anomalous diffraction (SAD) methods for 
the Se-OphAC18 data set. The model was further improved and re-
fined using COOT (42), REFMAC5 (43), and Phenix (44). All the 
other structures were solved by molecular replacement with 
OphAC18 as the initial search model using Phaser (45) and refined 
as described above. Each final model was verified with MolProbity 
(46). Refinement statistics were summarized in table S1, and electron 
density in fig. S6. Although the main chain electron density of the 
substrate peptide was clear, despite the relatively high resolution of the 
structures, the side chains of the substrate peptides could not be inter-
preted unambiguously in most cases. We attribute this to disorder 
within the register, that is, substrate peptide docks in multiple 
conformations in the crystal, which, although sharing the same 
backbone orientation, have different side chains. Consequently, al-
though we have modeled a particular register in the structures, our 
interpretations have avoided placing weight on the identity of the side 
chain at position i. To obtain the ratio of SAM, SAH, or sinefungin 
in crystals, structures of Y63F-sinefungin (50 mM), R72A-SAM, 
Y76F-SAM, Y98A-SAM, and W400A-sinefungin were refined for 
many rounds by Phenix until occupancy of SAH, SAM, or sinefungin 
(starting point is 0.5 occupancy of SAM/sinefungin and SAH) no lon-
ger change. Electrostatic surfaces were calculated with CCP4MG (47). 
All crystallographic figures were generated using Pymol (Schrödinger 
LLC). Coordinates and data have been deposited with the wwPDB 
(Worldwide Protein Data Bank).
MD simulations and QM calculations
All MD simulations were performed under isothermic-isobaric con-
ditions at 298 K using the GROMOS package of programs (48). The at-
omistic GROMOS force field 54A7 (49) was used with the simple point 
charge (SPC) model as water model. Initial parameters for SAM and 
SAH were taken from the Automated Topology Builder server (50) 
and adjusted to match the parameters of related substructures in ami-
no acids. The bond lengths were constrained to the ideal values ap-
plying the SHAKE algorithm (51). The temperature was maintained 
close to its reference value T = 298 K by weak coupling to a temperature 
bath with a relaxation time of 0.1 ps (52). The pressure was maintained 
close to its reference value P = 1.013 bar (1 atm) by weak coupling to 
a pressure bath with a relaxation time of 0.5 ps and using the isother-
mal compressibility kT = 4.575 × 10−4 (kJ mol−1 nm−3)−1. Newton’s 
equations of motion were integrated using the leap-frog scheme (53) 
with a time step of 2 fs. A reaction field force (54) was applied using the 
relative dielectric permittivity rf = 61(55). As initial coordinates, the 
crystal structure of OphAC6 with SAM was taken. All crystal waters 
were removed with the exception of one water molecule buried in 
each binding pocket. The two magnesium cations were included. The 
missing loop between residues 268 and 277 in monomer A was mod-
eled using the webserver ModLoop (56). The missing loops between 
residues 380 and 405 in monomer A and between residues 379 and 
404 in monomer B were not modeled due to their length, that is, the 
substrates in the binding pockets were not connected to the parent 
proteins. The dimer complex was energy-minimized in vacuum and 
solvated in a cubic box of 21516 SPC water molecules. The solvent was 
energy-minimized with the protein position restrained. A thermaliza-
tion in five steps from 60 to 298 K was performed with the position 
restraints decreased from 2.5 × 104 kJ mol−1 nm−2 to zero, with the 
first four steps being 20 ps under constant-volume condition and the 
last step being 500 ps under isothermic-isobaric condition. A pro-
duction run of 20 ns was performed. The simulations were analyzed 
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in terms of backbone atom- positional rmsd and secondary structure 
motifs using the GROMOS++ analysis programs (fig. S8) (57). As QM 
calculations require a defined location of the proton in the product 
state for convergence, a snapshot where the water molecules formed 
a hydrogen-bonding network up to the deprotonated carboxy group 
of SAM was taken from the MD simulation as a starting point. If 
necessary, the orientation of key residues in the binding pocket was 
modified using PyMol (Schrödinger LLC) to obtain a hydrogen-bonding 
network similar to that observed in the crystal structure of OphAC6. 
The final geometry is shown in Fig. 5B.
All electronic structure calculations were performed with the quan-
tum chemistry software package Gaussian09 Rev. D1 (Gaussian Inc.), 
using Kohn-Sham density functional theory (58). B3LYP (59, 60) and 
TPSSH (61) were used as exchange correlation functional. The or-
bitals were expanded in the 6-31G** basis set (62, 63) in conjunction 
with density fitting for the two-electron integrals (64, 65). The size 
of the integration grid was chosen as UltraFine. To account for solv-
ation effects, a reaction field within the integral equation formalism 
model (66) was applied. As solvent, diethylether with a dielectric con-
stant of  = 4.24 was chosen, which is a common approximation for 
the surrounding enzyme environment (67). For the minimization of 
the electronic energy with respect to the nuclear coordinates and the 
location of the transition state, atoms far away from the reaction 
center were kept frozen. More specifically, the methyl group of SAM 
was chosen as center, and all atoms with a distance >7 Å to it were 
constrained (fig. S8). Once a saddle point was located, a unique and 
coordinate-independent reaction coordinate, the so-called intrinsic 
reaction coordinate (IRC), was followed. By definition, this corre-
sponds to an imaginary minimum energy trajectory in mass-weighted 
Cartesian coordinates with the initial direction indicated by the nor-
mal mode of the imaginary frequency of the transition state (68). In 
essence, this trajectory corresponds to the steepest decent path or 
minimum energy path (69, 70). The IRCs of step 1 and 2 are shown 
in fig. S8.
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